Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

Mackenzie Cancer Research Publications 2015-2017

2000-2004 2005-20092010-20142015 2016 2017 2018-2020

2017

  • de Jong, L. C., Cree, S., Lattimore, V., Wiggins, G. A. R., Spurdle, A. B., kConFab Investigators, Miller, A., Kennedy, M. A., & Walker, L. C. (2017). Nanopore sequencing of full-length BRCA1 mRNA transcripts reveals co-occurrence of known exon skipping events. Breast Cancer Research, 19, 127
  • Walker LC, Pearson JF, Wiggins GAR, Giles GG, Hopper JL, Southey MC. Increased genomic burden of germline copy number variants is associated with early onset breast cancer: Australian Breast Cancer Family Registry Breast Cancer Research (2017) 19: 30.
  • Shimelis H, Mesman RL, Catharina Von Nicolai, Asa Ehlen, Lucia Guidugli, Charlotte Martin, Fabienne M. Calleja, Huong Meeks, Emily Hallberg, Jamie Hinton, Jenna Lilyquis, Chunling Hu, Cora M. Aalfs, Kristiina Aittomaki, Irene L. Andrulis, Hoda Anton-Culver, Volker Arndt, Matthias W. Beckmann, Javier J. Benitez, Natalia Bogdanova, Stig E. Bojesen, Manjeet K. Bolla, Anne-Lise Borresen-Dale, Hiltrud Brauch, Paul Brennan, Hermann Brenner, Annegien Broeks, Barbara Brouwers, Thomas Bruning, Barbara Burwinkel, Jenny Chang-Claude, Georgia Chenevix-Trench, Ching-Yu Cheng, Ji-Yeob Choi, J. Margriet Collée, Angela Cox, Simon S. Cross, Kamila Czene, Hatef Darabi, Joe Dennis, Thilo Dork, Isabel dos Santos Silva, Alison M. Dunning, Peter A. Fasching, Jonine D. Figueroa, Henrik Flyger, Montserrat Garcia-Closas, Graham G. Giles, Gord Glendon, Pascal Guenel, Christopher A. Haiman, Per Hall, Ute Hamann, Mikael Hartman, Frans B. Hogervorst, Antoinette Hollestelle, John L. Hopper,  Hidemi Ito, Anna Jakubowska, Daehee Kang, Veli-Matti Kosma, Vessela Kristensen, Kah-Nyin Lai, Diether Lambrechts, Loic Le Marchand, Jingmei Li, Annika Lindblom, Artitaya Lophatananon, Jan Lubinski, Eva Machackova, Arto Mannermaa, Sara Margolin, Frederik Marme, Keitaro Matsuo, Hui Miao, Kyriaki Michailidou, Roger L. Milne, Kenneth Muir, Susan L. Neuhausen, Heli Nevanlinna, Janet E. Olson, Curtis Olswold, Jan C. Oosterwijk, Ana Osorio, Paolo Peterlongo, Julian Peto, Paul D. Pharoah, Katri Pylkäs, Paolo Radice, Muhammad U. Rashid, Valerie Rhenius, Anja Rudolph, Suleeporn Sangrajrang, Elinor J. Sawyer, Marjanka K. Schmidt, Minouk J. Schoemaker, Caroline M. Seynaeve, Mitul Shah, Chen-Yang Shen, Martha J. Shrubsole, Xiao-Ou Shu, Susan L. Slager, Melissa C. Southey, Daniel O. Stram, Anthony J. Swerdlow, Soo Hwang Teo, Ian Tomlinson, Diana Torres, Therese Truong, Christi J. van Asperen, Lizet E. van der Kolk, Qin Wang, Robert Winqvist, Anna H. Wu, Jyh-Cherng Yu, Wei Zheng, Ying Zheng, Jennifer Leary, Logan C. Walker, Lenka Foretova, Florentia Fostira, Kathleen Claes, Liliana Varesco, Setareh Moghadasi, Douglas F. Easton, Amanda B. Spurdle, Peter Devilee, Harry Vrieling, Alvaro N. Monteiro, David E. Goldgar, Aura Carreira, Maaike P. Vreeswijk. BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer. Cancer Res (2017) 77(11); 1–11
  • Walker LC, Marquart L, Pearson JF, Wiggins GA, O'Mara TA, Parsons MT; BCFR., Barrowdale D, McGuffog L, Dennis J, Benitez J, Slavin TP, Radice P, Frost D; EMBRACE., Godwin AK, Meindl A, Schmutzler RK; GEMO Study Collaborators., Isaacs C, Peshkin BN, Caldes T, Hogervorst FB; HEBON., Lazaro C, Jakubowska A, Montagna M; KConFab Investigators., Chen X, Offit K, Hulick PJ, Andrulis IL, Lindblom A, Nussbaum RL, Nathanson KL, Chenevix-Trench G, Antoniou AC, Couch FJ, Spurdle AB. Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers. Eur J Hum Genet. (2017) doi: 10.1038/ejhg.2016.203. [Epub ahead of print]
  • Wohlrab C, Phillips E, Dachs GU. Vitamin C Transporters in Cancer: Current Understanding and Gaps in Knowledge. Front Oncol. 2017 Apr 24;7:74. doi: 10.3389/fonc.2017.00074.
  • Robinson B, Currie M, Phillips E, Dachs G, Strother M, Morrin H, Davey V, Frampton C. Body mass index (BMI): association with clinicopathological factors and outcome of women with newly diagnosed breast cancer in New Zealand. N Z Med J. 2017;130(1451):46-56.
  • Wohlrab C, Phillips E, Dachs GU. Vitamin C transporters in cancer: current understanding and gaps in knowledge. Front. Oncol 2017;7:74.

^ Top of Page

2016

  • Campbell EJ, Vissers MC, Wohlrab C, Hicks KO, Strother RM, Bozonet SM, Robinson BA, Dachs GU. Pharmacokinetic and anti-cancer properties of high dose ascorbate in solid tumours of ascorbate-dependent mice. Free Radic Biol Med. 2016 Oct;99:451-462. doi: 10.1016/j.freeradbiomed.2016.08.027
  • Campbell EJ, Vissers MCM, Dachs GU. Ascorbate availability affects tumor implantation-take rate and increases tumor rejection in Gulo–/– mice. Hypoxia 2016, 4:41-52
  • Bonifert G, Folkes L, Gmeiner C, Dachs G, Spadiut O. Recombinant horseradish peroxidase variants for targeted cancer treatment. Cancer Med. 2016 Mar 15. doi: 10.1002/cam4.668
  • de la Hoya, M., Sourarieh, O., López-Perolio, I., Vega, A., Walker, L. C., van Ierland, Y., … Spurdle, A. B. (2016). Combined genetic and splicing analysis of BRCA1 c.[594-2A>C; 641A>G] highlights the relevance of naturally occurring in-frame transcripts for developing disease gene variant classification algorithms. Human Molecular Genetics. Advance online publication. doi: 10.1093/hmg/ddw094
  • Fackenthal, J. D., Yoshimatsu, T., Zhang, B., de Garibay, G. R., Colombo, M., De Vecchi, G., … Walker, L. C., … de la Hoya, M. (2016). Naturally occurring BRCA2 alternative mRNA splicing events in clinically relevant samples. Journal of Medical Genetics. Advance online publication. doi: 10.1136/jmedgenet-2015-103570
  • Morley-Bunker, A., Walker, L. C., Currie, M. J., Pearson, J., & Eglinton, T. (2016). Translating colorectal cancer genetics into clinically useful biomarkers. Colorectal Disease. Advance online publication. doi: 10.1111/codi.13334

^ Top of Page

2015

  • Fernando C, Frizelle F, Wakeman C, Frampton C, Robinson B. Colorectal Multidisciplinary Meeting Audit to determine patient benefit, Aust New Zealand J Surgery, 2015, In Press.
  • Lattimore V, Currie M, Lintott C, Sullivan J, Robinson B, Walker LC. Meeting the challenges of interpreting variants of unknown clinical significance in BRCA testing. NZ Med J. 128(1419), 6613 (2015)
  • Dachs G, Phillips E, Phung Y, Dyer A, Willis J, Currie M, Robinson B. Tumour Growth in mice resistant to diet-induced obesity. J Molec Biochem 2015, 4(2), 42-49.
  • Gerring Z, Pearson J, Morrin H, Robinson B, Harris G, Walker L. Phosphohistone H3 outperforms Ki67 as a marker of outcome for breast cancer patients. Histopathology 2015, Advance on line publication.
  • Richardson A, Currie M, Robinson B, Morrin H, Phung Y, Pearson J, Anderson T, Potter J, Walker L. Cytomegalovirus and Epstein-Barr virus in breast cancer. PLOS One, 2015, 10(2) e0118989.
  • Ko D, Norriss A, Harrington C, Robinson B, James M. Hypofractionated radiation treatment following mastectomy in early breast cancer: The Christchurch experience. J Med Imaging Radiat Oncol 2015, 59(2),243-7.
  • Campbell E, Vissers M, Bozonet S, Dyer A, Robinson B, Dachs G. Restoring physiological levels of ascorbate slows tumour growth and moderates HIF-1 pathway activity in Gulo-/- mice. Cancer Medicine, 2015, 4(2),303-14.
  • Walker LC, Wiggins GAR, Pearson JF. The Role of Constitutional Copy Number Variants in Breast Cancer. Microarrays 4, 324-338 (2015)
  • Moir-Meyer G, Pearson JF, Lose F, The Australian National Endometrial Cancer Study Group, Scott R, McEvoy M, Attia J, Holliday E, The Hunter Community Study, Studies of Epidemiology and Risk Factors in Cancer Heredity, Pharoah P, Dunning A, Thompson D, Easton D, Spurdle AB, Walker LC. Rare Germline Copy Number Deletions of Likely Functional Importance are Implicated in Endometrial Cancer Predisposition. Hum Genet 34(3):269-78 (2015)
  • Slatter TL, Royds JA, Pilbrow A, Ahn A, Morrin H, Framptom C, Russell I, Moravec CS, Sweet W, Tang W, Currie MJ and Hung NA(2015) The rs11515 polymorphism is more frequent and associated with aggressive breast tumors with increased ANRIL and decreased p16INK4A expression. Front. Oncol. 5:306. doi:10.3389/fonc.2015.00306
  • BD Hock, JL McKenzie, NB Cross, MJ Currie. Dynamic changes in myeloid derived suppressor cell subsets following renal transplant: A prospective study.  Transplant Immunology; 32(3):164-71 (2015)

^ Top of Page